Cancer Epigenetics: New Mechanisms and Therapeutic Opportunities joint with Gene Regulation: From Mechanisms to Disease Scientific Organizers: Cigall Kadoch and Christopher Vakoc Date: January 26 - 30, 2020
Location: Keystone Resort, Keystone, CO, USA The 2020 Keystone Symposia Cancer Epigenetics: New Mechanisms and Therapeutic Opportunities in conjunction with the joint conference, Gene Regulation: From Mechanisms to Disease, co-organized by Karen Adelman and Patrick Cramer, will highlight state-of-the art advances in methods, mechanistic insights, and drug discovery efforts across these interrelated fields. Furthermore, results from exome- and genome-wide sequencing efforts point toward major roles for chromatin regulatory machinery in cancer. These data emphasize the immediate need for mechanistic understanding and, in parallel, the identification of novel strategies toward therapeutic targeting for this class of cancer drivers. This conference will help to foster interactions and new connections between basic biologists focused on chromatin architecture, structure, and function with translational biologists focused on model systems for mechanistic interrogation. Participants will attend sessions that will feature the presentation of new methods and techniques in systems biology, imaging, genomics, and drug discovery approaches. Other topics will explore the roles for enhancer structure, genome organization and topology on DNA accessibility and gene expression. Finally, this conference will expose trainees across a wide range of international, interdisciplinary laboratories to cutting edge science in cancer epigenetics and related fields, hoping to further their interests and commitment to this area of biologic research The concurrent joint conference on 'Gene Regulation: From Mechanisms to Disease' is another unique, one-of-a-kind aspect of this conference, allowing participants to attend talks in their interest areas across two closely-related disciplines. Our cancer-centered audience will have an opportunity to attend select talks as well as two joint sessions, which all the organizers have carefully considered and designed together. Scholarship Deadline: October 1 2019 details
Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies.
Registered attendees of one meeting in a joint pair may participate in sessions of the other, pending space availability.
Abstract submission is now closed. Registered attendees may bring a poster onsite. Please contact our office at +1 800-253-0685; +1 970-262-1230 or email info@keystonesymposia.org if you are interested.
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:
Agios Pharmaceuticals
GSK Foundation
We gratefully acknowledge the generous grant for this conference provided by: National Cancer Institute (NCI)Grant No. 1R13CA243574-01 Funding for this conference was made possible (in part) by 1R13CA243574-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government. |